Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 292
Selected: 0
NCT IDTitle
NCT00262951Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00725062Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00895414Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
NCT00373152MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT00625092Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT06792825HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT06030648MT2022-01: MSCs for ALD
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT01056601Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT00167206Stem Cell Transplantation for Fanconi Anemia
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT02118311Treg Cells for AGVHD in Non-myeloablative UCB Transplant
NCT00290641Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
NCT00630565Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT01705288Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT00274846Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT02989844Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
NCT02206971Biomarker Feedback for Smoking Cessation
NCT00617929Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT06412497MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
NCT04740008Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
NCT00176917Stem Cell Transplantation for Hurler
NCT00769990Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT00345865Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
NCT00619021Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT00176839Stem Cell Transplantation for Hematological Malignancies
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation